Related Experiment Videos
Late breast recurrence after lumpectomy and irradiation
Summary
Late breast cancer recurrences after lumpectomy and radiotherapy are common, even beyond 5 years. These late events are operable and do not impact survival, supporting breast-conserving surgery.
Area of Science:
- Oncology
- Surgical Oncology
- Radiotherapy
Background:
- Early breast cancer treatment often involves lumpectomy and radiotherapy.
- Long-term follow-up is crucial for understanding recurrence patterns and survival outcomes.
Purpose of the Study:
- To analyze the incidence and characteristics of both early and late breast cancer recurrences.
- To evaluate the impact of recurrence timing on prognosis and survival.
- To inform treatment decisions regarding mastectomy versus breast-conserving surgery.
Main Methods:
- Retrospective analysis of 276 early breast cancer patients.
- Follow-up duration of 10-21 years post-lumpectomy and radiotherapy.
- Assessment of recurrence rates, timing, operability, and survival outcomes.
Main Results:
- 15.6% recurrence in the treated breast; 7.2% contralateral breast cancer.
- 63% of recurrences occurred within 5 years; termed 'late failures' thereafter.
- Late recurrences were more common in T1 tumors (53%) vs. T2 (25%).
- Early recurrences had a higher rate of inoperability (26%) and adverse survival impact.
- Late recurrences were all operable, with 5-year survival post-salvage therapy at 62% and no apparent decrease in survival.
Conclusions:
- The treated breast remains at risk for late cancer recurrence beyond 5 years.
- Late recurrences have a prognosis similar to contralateral breast cancer and are operable.
- Findings do not support routine mastectomy; breast-conserving approaches are viable.